Skip to main content
Caplight Logo









Peekcell

Peekcell

Private
PalaiseauHealthcare & Life Scienceshttps://peekcell.fr

Last Round

Seed

Dec 1, 2024

Total Funding Raised

$1.35M

Company Overview

Peekcell operates in Healthcare & Life Sciences and is based in Palaiseau. Its latest recorded funding round was a Seed round in December 2024.

Peekcell is a medtech company that develops non-invasive cancer screening solutions using biomarker analysis and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Peekcell Comparables

Compare Peekcell with similar companies based on industry and business-model similarity.

No comparables are published for Peekcell. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Peekcell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Antoine Droneau

Co-founder & COO

Founding Team

Gwendoline Tallec

Cofondatrice et CTO

Executive Team

For institutional investors. Book with your work email.

Peekcell Investors

Notable investors and investment history

Peekcell investors
InvestorRounds
WilcoSeed
Réseau Entreprendre EssonneSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 54% MoM.

  • Dec 1, 2024

    $1.35M round led by Wilco

Book a demo to see all signals

For institutional investors. Book with your work email.

Peekcell Filings

Explore SEC and related filing metadata, where available.

Peekcell filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Peekcell's valuation, stock price, and market status.

Is Peekcell a public or private company?

Peekcell is a private company.

What is the current stock price of Peekcell?

Peekcell is a private company, so its shares have no public market price. Caplight tracks Peekcell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Peekcell worth (valuation)?

Valuation information for Peekcell is not publicly available.

Can I buy Peekcell stock?

Peekcell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Peekcell's last funding round?

Peekcell's most recent funding round was Seed on December 1, 2024.

Who are the main investors in Peekcell?

Key investors in Peekcell include Wilco, Réseau Entreprendre Essonne.

Will Peekcell IPO soon?

No public IPO plans have been announced for Peekcell.

How can I track Peekcell secondary market activity?

Caplight tracks bids, offers, and trades in Peekcell's shares on secondary markets.

Firmographic Details

HeadquartersPalaiseau
Employee Range7
Year Founded2023
Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?